Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Proctor

Showing results (91-100 of 197) with videos related to

Pageof 20
Sort By:
Blood Reviews|September 1, 1994
Autologous bone marrow transplantation in acute lymphoblastic leukaemiaG H Jackson, P R Taylor, A L Lennard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNUA L Lennard, P J Carey, G H Jackson, et al.
Clinical Radiology|May 1, 1981
Multiple myeloma: radiology or bone scanning?R C Leonard, J P Owen, S J Proctor, et al.
Leukemia Research|January 1, 1990
De novo Ph negative T-cell lymphoblastic leukaemia associated with bcr gene rearrangementP G Middleton, E V Davison, M M Reid, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal toxicity due to intermediate-dose methotrexateA N Stark, G Jackson, P J Carey, et al.
Journal of the American Chemical Society|November 12, 2019
Predictive Multivariate Linear Regression Analysis Guides Successful Catalytic Enantioselective Minisci Reactions of DiazinesJolene P Reid, Rupert S J Proctor, Matthew S Sigman, et al.
Clinical Radiology|March 1, 1988
Hodgkin's disease involving the large bowelA G Hall, R Taylor, R G Evans, et al.
Lancet (London, England)|May 13, 1995
Low frequency of myelodysplasia after autologous bone marrow transplantationP Taylor, G H Jackson, A Lennard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working PartyS J Proctor, P Taylor, P Donnan, et al.
Cytokine|March 1, 1994
Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin modelA M Dickinson, L Sviland, G Jackson, et al.
Pageof 20

Showing results (91-100 of 197) with videos related to

Sort By:
Pageof 20
Blood Reviews|September 1, 1994
Autologous bone marrow transplantation in acute lymphoblastic leukaemiaG H Jackson, P R Taylor, A L Lennard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
An effective oral combination in advanced relapsed Hodgkin's disease prednisolone, etoposide, chlorambucil and CCNUA L Lennard, P J Carey, G H Jackson, et al.
Clinical Radiology|May 1, 1981
Multiple myeloma: radiology or bone scanning?R C Leonard, J P Owen, S J Proctor, et al.
Leukemia Research|January 1, 1990
De novo Ph negative T-cell lymphoblastic leukaemia associated with bcr gene rearrangementP G Middleton, E V Davison, M M Reid, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Severe renal toxicity due to intermediate-dose methotrexateA N Stark, G Jackson, P J Carey, et al.
Journal of the American Chemical Society|November 12, 2019
Predictive Multivariate Linear Regression Analysis Guides Successful Catalytic Enantioselective Minisci Reactions of DiazinesJolene P Reid, Rupert S J Proctor, Matthew S Sigman, et al.
Clinical Radiology|March 1, 1988
Hodgkin's disease involving the large bowelA G Hall, R Taylor, R G Evans, et al.
Lancet (London, England)|May 13, 1995
Low frequency of myelodysplasia after autologous bone marrow transplantationP Taylor, G H Jackson, A Lennard, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working PartyS J Proctor, P Taylor, P Donnan, et al.
Cytokine|March 1, 1994
Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin modelA M Dickinson, L Sviland, G Jackson, et al.
Pageof 20